Literature DB >> 32531120

Histological findings in chilblain lupus-like COVID lesions: in search of an answer to understand their aetiology.

A Rodríguez-Villa Lario1, D Vega-Díez1, M González-Cañete1, A Gómez-Zubiaur1, R Pérez-Mesonero1, M Bandini1, I Polo-Rodríguez1, D Vélez-Velázquez2, L Trasobares-Marugán1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32531120      PMCID: PMC7307075          DOI: 10.1111/jdv.16733

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   9.228


× No keyword cloud information.
To the Editor, We read with great interest the article by Piccolo et al. describing chilblain‐like lesions (CLL) on feet and hands during the COVID‐19 pandemic. They mention the rate of association to autoimmune conditions was very low, which led to exclude a note autoimmune disorder as main cause of CLL. Here, we hypothesize the possible relationship between the development of these lesions and immune‐chained phenomena following viral infection in a certain group of patients. Although perniosis is a frequent phenomenon, it seems reasonable to establish a causal relationship between these lesions and the coronavirus given the significant increase in these lesions in the epidemiological context that we are living in. , Kolivras et al. have recently described the histological manifestations in a 23‐year‐old caucasian male with pernicious lesions and a confirmed rt‐PCR positive for COVID‐19 without other analytical alterations. We reaffirm the similarity between these lesions and those found in lupus chilblain. We present another case of an 17‐year‐old male, caregiver of a patient convalescing from COVID pneumonia, who presented acral lesions of 2 days' evolution compatible with the acromanifestations described (Fig. 1). Blood analysis revealed an elevation of IgA. Antinuclear antibodies were negative, and cryoglobulins were not detected. Rt‐PCR for COVID resulted negative and serologies showed positive IgG with negative IgM. CBC showed no cytopenias and haemostasis, including D‐dimer, was normal. A 4 mm punch biopsy was performed on one of the lesions (Fig. 2a–d), where marked hydropic degeneration of the basal layer was observed with isolates necrotic keratinocyte. In the papillary and reticular dermis, a moderate lymphocyte infiltration was observed around the vessels as sleeves. The endothelium was conspicuously prominent, without visualizing fibrinoid necrosis. A dense perieccrine infiltration was also evident. Immunochemistry with CD 123 resulted positive, notably around vessels and sweat glands. No direct immunofluorescence was performed.
Figure 1

Periungueal erythema in second and third finger toe.

Figure 2

(a) Haematoxylin–eosin 4× stain: hydropic degeneration of the basal layer with isolates necrotic keratinocyte. In papillary and reticular dermis, moderate lymphocyte infiltrate around the vessels. Note the endothelium conspicuously prominent, without visualizing fibrinoid necrosis. A dense perieccrine infiltration was also evident. (b) Closer look up, 20×. (c) Positive Immunochemistry CD123 4×, mostly around vessels and adnexal structures. (d) Closer look up 20×: positive CD 123 around vessels.

Periungueal erythema in second and third finger toe. (a) Haematoxylin–eosin 4× stain: hydropic degeneration of the basal layer with isolates necrotic keratinocyte. In papillary and reticular dermis, moderate lymphocyte infiltrate around the vessels. Note the endothelium conspicuously prominent, without visualizing fibrinoid necrosis. A dense perieccrine infiltration was also evident. (b) Closer look up, 20×. (c) Positive Immunochemistry CD123 4×, mostly around vessels and adnexal structures. (d) Closer look up 20×: positive CD 123 around vessels. The similarity of these acral lesions with chilblain lupus lesions in this population group, mostly young patients, may be due to the type of immune response triggered by the interaction of COVID‐19 with the immune system of these individuals. IFN type I levels are known to correlate with age. Infection of COVID‐19 (as well as other viruses such as respiratory syncytial virus) would produce, in paediatric patients, an IFN‐mediated response that, when induced prematurely, would control the viral infection. However, in adults, SARS‐Cov‐2 infection would produce a mute of interferon pathway regulatory genes (ISG) which prevents successful inhibition of viral spread. The understanding of the molecular basis of innate immunity has led to identification of IFNs as a central mediator in the pathogenesis of systemic lupus erythematosus (SLE). Type I IFNs, produced mainly by plasmacytoid dendritic cells, have been claimed important in the pathogenesis of SLE skin lesions. We propose that the detection of these subspecialized cells by immunochemistry with the CD 123 marker, as producers of IFN in skin, may help to understand the underlying pathophysiology. The combination of these two facts could be responsible for the appearance of lupus‐like lesions preferably in young patients. We describe as well a dense and striking inflammatory infiltration in the vascular wall with tumefaction of the endothelial cells, without finding any fibrinoid necrosis nor microthrombi as discussed by Landa et al. It has been already proven the existence of viral inclusion bodies and viral particles in endothelial cells and the detection of mononuclear cell infiltrates within the intima of vessels in different organs. We propose that similar changes are responsible for the endothelitis observed in our skin specimen. However, there are still unanswered questions, such as the delay in the appearance or why other skin lesions resembling lupus have not been described to date. Further research is needed to answer these questions.

Conflicts of interest

The authors have no conflict of interest to declare.

Funding sources

The article has no funding source.
  7 in total

Review 1.  Pathogenesis of Skin Injury of Systemic Lupus Erythematosus.

Authors:  Guo-Min Deng
Journal:  Curr Rheumatol Rep       Date:  2018-02-21       Impact factor: 4.592

2.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

3.  Chilblain-like lesions on feet and hands during the COVID-19 Pandemic.

Authors:  Nerea Landa; Marta Mendieta-Eckert; Pablo Fonda-Pascual; Teresa Aguirre
Journal:  Int J Dermatol       Date:  2020-04-24       Impact factor: 2.736

4.  Endothelial cell infection and endotheliitis in COVID-19.

Authors:  Zsuzsanna Varga; Andreas J Flammer; Peter Steiger; Martina Haberecker; Rea Andermatt; Annelies S Zinkernagel; Mandeep R Mehra; Reto A Schuepbach; Frank Ruschitzka; Holger Moch
Journal:  Lancet       Date:  2020-04-21       Impact factor: 79.321

5.  Coronavirus (COVID-19) infection-induced chilblains: A case report with histopathologic findings.

Authors:  Athanassios Kolivras; Florence Dehavay; Daphné Delplace; Francesco Feoli; Isabelle Meiers; Laurenzo Milone; Catherine Olemans; Ursula Sass; Anne Theunis; Curtis T Thompson; Laura Van De Borne; Bertrand Richert
Journal:  JAAD Case Rep       Date:  2020-04-18

6.  Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.

Authors:  V Piccolo; I Neri; C Filippeschi; T Oranges; G Argenziano; V C Battarra; S Berti; F Manunza; A B Fortina; V Di Lernia; V Boccaletti; G De Bernardis; B Brunetti; C Mazzatenta; A Bassi
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-15       Impact factor: 6.166

7.  Acral cutaneous lesions in the time of COVID-19.

Authors:  S Recalcati; T Barbagallo; L A Frasin; F Prestinari; A Cogliardi; M C Provero; E Dainese; A Vanzati; F Fantini
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-27       Impact factor: 6.166

  7 in total
  3 in total

1.  COVID toes: where do we stand with the current evidence?

Authors:  Marie Baeck; Anne Herman
Journal:  Int J Infect Dis       Date:  2020-10-16       Impact factor: 3.623

Review 2.  Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.

Authors:  Jayakanthan Kabeerdoss; Rakesh Kumar Pilania; Reena Karkhele; T Sathish Kumar; Debashish Danda; Surjit Singh
Journal:  Rheumatol Int       Date:  2020-11-21       Impact factor: 2.631

Review 3.  A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.

Authors:  Athanassios Kolivras; Curtis Thompson; Ievgenia Pastushenko; Marisa Mathieu; Pascal Bruderer; Marine de Vicq; Francesco Feoli; Saadia Harag; Isabelle Meiers; Catherine Olemans; Ursula Sass; Florence Dehavay; Ali Fakih; Xuan-Lan Lam-Hoai; Alice Marneffe; Laura Van De Borne; Valerie Vandersleyen; Bertrand Richert
Journal:  J Cutan Pathol       Date:  2021-08-09       Impact factor: 1.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.